Global Lung Cancer Diagnostic Tests Market Research Report 2024

Report ID: 1977752 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Lung Cancer Diagnostic Tests Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Immunoassays
        1.2.3 Flow Cytometry
        1.2.4 Rapid Tests
        1.2.5 Molecular Assays
        1.2.6 Tissue Arrays
        1.2.7 Circulating Tumor Cells
        1.2.8 Pharmacodiagnostics
        1.2.9 Biomarkers
        1.2.10 Other Diagnostics Methods
    1.3 Market by Application
        1.3.1 Global Lung Cancer Diagnostic Tests Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Precision Medicine
        1.3.3 Personalized Medicine
        1.3.4 Cancer Monitoring
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Lung Cancer Diagnostic Tests Market Perspective (2017-2028)
    2.2 Lung Cancer Diagnostic Tests Growth Trends by Region
        2.2.1 Lung Cancer Diagnostic Tests Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Lung Cancer Diagnostic Tests Historic Market Size by Region (2017-2022)
        2.2.3 Lung Cancer Diagnostic Tests Forecasted Market Size by Region (2023-2028)
    2.3 Lung Cancer Diagnostic Tests Market Dynamics
        2.3.1 Lung Cancer Diagnostic Tests Industry Trends
        2.3.2 Lung Cancer Diagnostic Tests Market Drivers
        2.3.3 Lung Cancer Diagnostic Tests Market Challenges
        2.3.4 Lung Cancer Diagnostic Tests Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Lung Cancer Diagnostic Tests Players by Revenue
        3.1.1 Global Top Lung Cancer Diagnostic Tests Players by Revenue (2017-2022)
        3.1.2 Global Lung Cancer Diagnostic Tests Revenue Market Share by Players (2017-2022)
    3.2 Global Lung Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Lung Cancer Diagnostic Tests Revenue
    3.4 Global Lung Cancer Diagnostic Tests Market Concentration Ratio
        3.4.1 Global Lung Cancer Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Diagnostic Tests Revenue in 2021
    3.5 Lung Cancer Diagnostic Tests Key Players Head office and Area Served
    3.6 Key Players Lung Cancer Diagnostic Tests Product Solution and Service
    3.7 Date of Enter into Lung Cancer Diagnostic Tests Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Lung Cancer Diagnostic Tests Breakdown Data by Type
    4.1 Global Lung Cancer Diagnostic Tests Historic Market Size by Type (2017-2022)
    4.2 Global Lung Cancer Diagnostic Tests Forecasted Market Size by Type (2023-2028)
5 Lung Cancer Diagnostic Tests Breakdown Data by Application
    5.1 Global Lung Cancer Diagnostic Tests Historic Market Size by Application (2017-2022)
    5.2 Global Lung Cancer Diagnostic Tests Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Lung Cancer Diagnostic Tests Market Size (2017-2028)
    6.2 North America Lung Cancer Diagnostic Tests Market Size by Country (2017-2022)
    6.3 North America Lung Cancer Diagnostic Tests Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Lung Cancer Diagnostic Tests Market Size (2017-2028)
    7.2 Europe Lung Cancer Diagnostic Tests Market Size by Country (2017-2022)
    7.3 Europe Lung Cancer Diagnostic Tests Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Lung Cancer Diagnostic Tests Market Size (2017-2028)
    8.2 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Country (2017-2022)
    8.3 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Lung Cancer Diagnostic Tests Market Size (2017-2028)
    9.2 Latin America Lung Cancer Diagnostic Tests Market Size by Country (2017-2022)
    9.3 Latin America Lung Cancer Diagnostic Tests Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Lung Cancer Diagnostic Tests Market Size (2017-2028)
    10.2 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Country (2017-2022)
    10.3 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Advpharma Inc
        11.1.1 Advpharma Inc Company Detail
        11.1.2 Advpharma Inc Business Overview
        11.1.3 Advpharma Inc Lung Cancer Diagnostic Tests Introduction
        11.1.4 Advpharma Inc Revenue in Lung Cancer Diagnostic Tests Business (2017-2022)
        11.1.5 Advpharma Inc Recent Development
    11.2 AIT Austrian Institute of Technology GmbH
        11.2.1 AIT Austrian Institute of Technology GmbH Company Detail
        11.2.2 AIT Austrian Institute of Technology GmbH Business Overview
        11.2.3 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Introduction
        11.2.4 AIT Austrian Institute of Technology GmbH Revenue in Lung Cancer Diagnostic Tests Business (2017-2022)
        11.2.5 AIT Austrian Institute of Technology GmbH Recent Development
    11.3 Courtagen Life Sciences Inc
        11.3.1 Courtagen Life Sciences Inc Company Detail
        11.3.2 Courtagen Life Sciences Inc Business Overview
        11.3.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Introduction
        11.3.4 Courtagen Life Sciences Inc Revenue in Lung Cancer Diagnostic Tests Business (2017-2022)
        11.3.5 Courtagen Life Sciences Inc Recent Development
    11.4 DiagnoCure Inc. (Inactive)
        11.4.1 DiagnoCure Inc. (Inactive) Company Detail
        11.4.2 DiagnoCure Inc. (Inactive) Business Overview
        11.4.3 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Introduction
        11.4.4 DiagnoCure Inc. (Inactive) Revenue in Lung Cancer Diagnostic Tests Business (2017-2022)
        11.4.5 DiagnoCure Inc. (Inactive) Recent Development
    11.5 BioMark Diagnostics Inc.
        11.5.1 BioMark Diagnostics Inc. Company Detail
        11.5.2 BioMark Diagnostics Inc. Business Overview
        11.5.3 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Introduction
        11.5.4 BioMark Diagnostics Inc. Revenue in Lung Cancer Diagnostic Tests Business (2017-2022)
        11.5.5 BioMark Diagnostics Inc. Recent Development
    11.6 BioMarker Strategies LLC
        11.6.1 BioMarker Strategies LLC Company Detail
        11.6.2 BioMarker Strategies LLC Business Overview
        11.6.3 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Introduction
        11.6.4 BioMarker Strategies LLC Revenue in Lung Cancer Diagnostic Tests Business (2017-2022)
        11.6.5 BioMarker Strategies LLC Recent Development
    11.7 Emory University
        11.7.1 Emory University Company Detail
        11.7.2 Emory University Business Overview
        11.7.3 Emory University Lung Cancer Diagnostic Tests Introduction
        11.7.4 Emory University Revenue in Lung Cancer Diagnostic Tests Business (2017-2022)
        11.7.5 Emory University Recent Development
    11.8 Epigenomics AG
        11.8.1 Epigenomics AG Company Detail
        11.8.2 Epigenomics AG Business Overview
        11.8.3 Epigenomics AG Lung Cancer Diagnostic Tests Introduction
        11.8.4 Epigenomics AG Revenue in Lung Cancer Diagnostic Tests Business (2017-2022)
        11.8.5 Epigenomics AG Recent Development
    11.9 GlycoZym
        11.9.1 GlycoZym Company Detail
        11.9.2 GlycoZym Business Overview
        11.9.3 GlycoZym Lung Cancer Diagnostic Tests Introduction
        11.9.4 GlycoZym Revenue in Lung Cancer Diagnostic Tests Business (2017-2022)
        11.9.5 GlycoZym Recent Development
    11.10 HalioDx SAS
        11.10.1 HalioDx SAS Company Detail
        11.10.2 HalioDx SAS Business Overview
        11.10.3 HalioDx SAS Lung Cancer Diagnostic Tests Introduction
        11.10.4 HalioDx SAS Revenue in Lung Cancer Diagnostic Tests Business (2017-2022)
        11.10.5 HalioDx SAS Recent Development
    11.11 Louisville Bioscience, Inc.
        11.11.1 Louisville Bioscience, Inc. Company Detail
        11.11.2 Louisville Bioscience, Inc. Business Overview
        11.11.3 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Introduction
        11.11.4 Louisville Bioscience, Inc. Revenue in Lung Cancer Diagnostic Tests Business (2017-2022)
        11.11.5 Louisville Bioscience, Inc. Recent Development
    11.12 Mayo Clinic US
        11.12.1 Mayo Clinic US Company Detail
        11.12.2 Mayo Clinic US Business Overview
        11.12.3 Mayo Clinic US Lung Cancer Diagnostic Tests Introduction
        11.12.4 Mayo Clinic US Revenue in Lung Cancer Diagnostic Tests Business (2017-2022)
        11.12.5 Mayo Clinic US Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Lung Cancer Diagnostic Tests Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Immunoassays
    Table 3. Key Players of Flow Cytometry
    Table 4. Key Players of Rapid Tests
    Table 5. Key Players of Molecular Assays
    Table 6. Key Players of Tissue Arrays
    Table 7. Key Players of Circulating Tumor Cells
    Table 8. Key Players of Pharmacodiagnostics
    Table 9. Key Players of Biomarkers
    Table 10. Key Players of Other Diagnostics Methods
    Table 11. Global Lung Cancer Diagnostic Tests Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 12. Global Lung Cancer Diagnostic Tests Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 13. Global Lung Cancer Diagnostic Tests Market Size by Region (2017-2022) & (US$ Million)
    Table 14. Global Lung Cancer Diagnostic Tests Market Share by Region (2017-2022)
    Table 15. Global Lung Cancer Diagnostic Tests Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 16. Global Lung Cancer Diagnostic Tests Market Share by Region (2023-2028)
    Table 17. Lung Cancer Diagnostic Tests Market Trends
    Table 18. Lung Cancer Diagnostic Tests Market Drivers
    Table 19. Lung Cancer Diagnostic Tests Market Challenges
    Table 20. Lung Cancer Diagnostic Tests Market Restraints
    Table 21. Global Lung Cancer Diagnostic Tests Revenue by Players (2017-2022) & (US$ Million)
    Table 22. Global Lung Cancer Diagnostic Tests Market Share by Players (2017-2022)
    Table 23. Global Top Lung Cancer Diagnostic Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Diagnostic Tests as of 2021)
    Table 24. Ranking of Global Top Lung Cancer Diagnostic Tests Companies by Revenue (US$ Million) in 2021
    Table 25. Global 5 Largest Players Market Share by Lung Cancer Diagnostic Tests Revenue (CR5 and HHI) & (2017-2022)
    Table 26. Key Players Headquarters and Area Served
    Table 27. Key Players Lung Cancer Diagnostic Tests Product Solution and Service
    Table 28. Date of Enter into Lung Cancer Diagnostic Tests Market
    Table 29. Mergers & Acquisitions, Expansion Plans
    Table 30. Global Lung Cancer Diagnostic Tests Market Size by Type (2017-2022) & (US$ Million)
    Table 31. Global Lung Cancer Diagnostic Tests Revenue Market Share by Type (2017-2022)
    Table 32. Global Lung Cancer Diagnostic Tests Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 33. Global Lung Cancer Diagnostic Tests Revenue Market Share by Type (2023-2028)
    Table 34. Global Lung Cancer Diagnostic Tests Market Size by Application (2017-2022) & (US$ Million)
    Table 35. Global Lung Cancer Diagnostic Tests Revenue Market Share by Application (2017-2022)
    Table 36. Global Lung Cancer Diagnostic Tests Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 37. Global Lung Cancer Diagnostic Tests Revenue Market Share by Application (2023-2028)
    Table 38. North America Lung Cancer Diagnostic Tests Market Size by Country (2017-2022) & (US$ Million)
    Table 39. North America Lung Cancer Diagnostic Tests Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Europe Lung Cancer Diagnostic Tests Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Europe Lung Cancer Diagnostic Tests Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Region (2017-2022) & (US$ Million)
    Table 43. Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Region (2023-2028) & (US$ Million)
    Table 44. Latin America Lung Cancer Diagnostic Tests Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Latin America Lung Cancer Diagnostic Tests Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Country (2017-2022) & (US$ Million)
    Table 47. Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Country (2023-2028) & (US$ Million)
    Table 48. Advpharma Inc Company Detail
    Table 49. Advpharma Inc Business Overview
    Table 50. Advpharma Inc Lung Cancer Diagnostic Tests Product
    Table 51. Advpharma Inc Revenue in Lung Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
    Table 52. Advpharma Inc Recent Development
    Table 53. AIT Austrian Institute of Technology GmbH Company Detail
    Table 54. AIT Austrian Institute of Technology GmbH Business Overview
    Table 55. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Product
    Table 56. AIT Austrian Institute of Technology GmbH Revenue in Lung Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
    Table 57. AIT Austrian Institute of Technology GmbH Recent Development
    Table 58. Courtagen Life Sciences Inc Company Detail
    Table 59. Courtagen Life Sciences Inc Business Overview
    Table 60. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product
    Table 61. Courtagen Life Sciences Inc Revenue in Lung Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
    Table 62. Courtagen Life Sciences Inc Recent Development
    Table 63. DiagnoCure Inc. (Inactive) Company Detail
    Table 64. DiagnoCure Inc. (Inactive) Business Overview
    Table 65. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Product
    Table 66. DiagnoCure Inc. (Inactive) Revenue in Lung Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
    Table 67. DiagnoCure Inc. (Inactive) Recent Development
    Table 68. BioMark Diagnostics Inc. Company Detail
    Table 69. BioMark Diagnostics Inc. Business Overview
    Table 70. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Product
    Table 71. BioMark Diagnostics Inc. Revenue in Lung Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
    Table 72. BioMark Diagnostics Inc. Recent Development
    Table 73. BioMarker Strategies LLC Company Detail
    Table 74. BioMarker Strategies LLC Business Overview
    Table 75. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Product
    Table 76. BioMarker Strategies LLC Revenue in Lung Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
    Table 77. BioMarker Strategies LLC Recent Development
    Table 78. Emory University Company Detail
    Table 79. Emory University Business Overview
    Table 80. Emory University Lung Cancer Diagnostic Tests Product
    Table 81. Emory University Revenue in Lung Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
    Table 82. Emory University Recent Development
    Table 83. Epigenomics AG Company Detail
    Table 84. Epigenomics AG Business Overview
    Table 85. Epigenomics AG Lung Cancer Diagnostic Tests Product
    Table 86. Epigenomics AG Revenue in Lung Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
    Table 87. Epigenomics AG Recent Development
    Table 88. GlycoZym Company Detail
    Table 89. GlycoZym Business Overview
    Table 90. GlycoZym Lung Cancer Diagnostic Tests Product
    Table 91. GlycoZym Revenue in Lung Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
    Table 92. GlycoZym Recent Development
    Table 93. HalioDx SAS Company Detail
    Table 94. HalioDx SAS Business Overview
    Table 95. HalioDx SAS Lung Cancer Diagnostic Tests Product
    Table 96. HalioDx SAS Revenue in Lung Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
    Table 97. HalioDx SAS Recent Development
    Table 98. Louisville Bioscience, Inc. Company Detail
    Table 99. Louisville Bioscience, Inc. Business Overview
    Table 100. Louisville Bioscience, Inc. Lung Cancer Diagnostic TestsProduct
    Table 101. Louisville Bioscience, Inc. Revenue in Lung Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
    Table 102. Louisville Bioscience, Inc. Recent Development
    Table 103. Mayo Clinic US Company Detail
    Table 104. Mayo Clinic US Business Overview
    Table 105. Mayo Clinic US Lung Cancer Diagnostic TestsProduct
    Table 106. Mayo Clinic US Revenue in Lung Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
    Table 107. Mayo Clinic US Recent Development
    Table 108. Research Programs/Design for This Report
    Table 109. Key Data Information from Secondary Sources
    Table 110. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Lung Cancer Diagnostic Tests Market Share by Type: 2021 VS 2028
    Figure 2. Immunoassays Features
    Figure 3. Flow Cytometry Features
    Figure 4. Rapid Tests Features
    Figure 5. Molecular Assays Features
    Figure 6. Tissue Arrays Features
    Figure 7. Circulating Tumor Cells Features
    Figure 8. Pharmacodiagnostics Features
    Figure 9. Biomarkers Features
    Figure 10. Other Diagnostics Methods Features
    Figure 11. Global Lung Cancer Diagnostic Tests Market Share by Application in 2021 & 2028
    Figure 12. Precision Medicine Case Studies
    Figure 13. Personalized Medicine Case Studies
    Figure 14. Cancer Monitoring Case Studies
    Figure 15. Lung Cancer Diagnostic Tests Report Years Considered
    Figure 16. Global Lung Cancer Diagnostic Tests Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 17. Global Lung Cancer Diagnostic Tests Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 18. Global Lung Cancer Diagnostic Tests Market Share by Region: 2021 VS 2028
    Figure 19. Global Lung Cancer Diagnostic Tests Market Share by Players in 2021
    Figure 20. Global Top Lung Cancer Diagnostic Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Diagnostic Tests as of 2021)
    Figure 21. The Top 10 and 5 Players Market Share by Lung Cancer Diagnostic Tests Revenue in 2021
    Figure 22. North America Lung Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. North America Lung Cancer Diagnostic Tests Market Share by Country (2017-2028)
    Figure 24. United States Lung Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Canada Lung Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe Lung Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Europe Lung Cancer Diagnostic Tests Market Share by Country (2017-2028)
    Figure 28. Germany Lung Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Lung Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Lung Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Lung Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Lung Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Lung Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Lung Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Lung Cancer Diagnostic Tests Market Share by Region (2017-2028)
    Figure 36. China Lung Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Lung Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Lung Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Lung Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Lung Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Lung Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Latin America Lung Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Latin America Lung Cancer Diagnostic Tests Market Share by Country (2017-2028)
    Figure 44. Mexico Lung Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Brazil Lung Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Middle East & Africa Lung Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Lung Cancer Diagnostic Tests Market Share by Country (2017-2028)
    Figure 48. Turkey Lung Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Saudi Arabia Lung Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Advpharma Inc Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2017-2022)
    Figure 51. AIT Austrian Institute of Technology GmbH Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2017-2022)
    Figure 52. Courtagen Life Sciences Inc Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2017-2022)
    Figure 53. DiagnoCure Inc. (Inactive) Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2017-2022)
    Figure 54. BioMark Diagnostics Inc. Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2017-2022)
    Figure 55. BioMarker Strategies LLC Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2017-2022)
    Figure 56. Emory University Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2017-2022)
    Figure 57. Epigenomics AG Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2017-2022)
    Figure 58. GlycoZym Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2017-2022)
    Figure 59. HalioDx SAS Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2017-2022)
    Figure 60. Louisville Bioscience, Inc. Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2017-2022)
    Figure 61. Mayo Clinic US Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2017-2022)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Advpharma Inc
AIT Austrian Institute of Technology GmbH
Courtagen Life Sciences Inc
DiagnoCure Inc. (Inactive)
BioMark Diagnostics Inc.
BioMarker Strategies LLC
Emory University
Epigenomics AG
GlycoZym
HalioDx SAS
Louisville Bioscience, Inc.
Mayo Clinic US
Frequently Asked Questions
Lung Cancer Diagnostic Tests report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Lung Cancer Diagnostic Tests report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Lung Cancer Diagnostic Tests report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports